» Articles » PMID: 37629620

Predictors of Quality-of-Life Improvement at Different Minimum Clinically Important Difference Values in Patients with Chronic Obstructive Pulmonary Disease After Climatic Rehabilitation Treatment

Overview
Journal Life (Basel)
Specialty Biology
Date 2023 Aug 26
PMID 37629620
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The minimum clinically important difference (MCID) for the St George's Respiratory Questionnaire (SGRQ) is debated in chronic obstructive pulmonary disease (COPD) quality-of-life (QoL) assessments. This study aimed to determine whether there is a difference in predictors of clinically significant improvement between the traditional (value of 4) and newly proposed MCID SGRQ (value of 7) after climatic rehabilitation treatment. Climatic rehabilitation treatment consists of two main parts: climatotherapy, which typically involves the controlled exposure of individuals to natural environmental elements, and climatic rehabilitation, which includes other therapeutic factors such as physical activities as well as educating the patient to change their lifestyle.

Methods: This study included 90 consecutive patients diagnosed with COPD who underwent structured complex pulmonary rehabilitation in High Tatras, part of the Carpathian Mountains. The examination before and after treatment included spirometry, QoL assessment using the SGRQ, 6 min walk test (6-MWT), and the Borg, Beck and Zung scale.

Results: Patients showed statistically significant improvement after the intervention in FEV1, FEV1/FVC, 6-MWT, ( < 0.001), anxiety scores, depression, and improvement in dyspnoea both before and after the 6-MWT ( < 0.001). For both MCID for SGRQ levels 4 and 7, we confirmed the same predictors of clinical improvement for bronchial obstruction grade (spirometry) and exercise capacity (6-MWT), for quality of life in activity score and total score.

Conclusion: The results suggest that both the proposed MCID for SGRQ values could be sufficient to assess the clinical significance of the achieved change in health status when assessing the need for pulmonary rehabilitation comprising climatotherapy in patients with COPD.

Citing Articles

Prognostic Factors for Responders of Home-Based Pulmonary Rehabilitation-Secondary Analysis of a Randomized Controlled Trial.

Kim C, Choi H, Rhee C, Lee J, Oh J, Song J Healthcare (Basel). 2025; 13(3).

PMID: 39942497 PMC: 11817295. DOI: 10.3390/healthcare13030308.


Therapeutic efficacy and pharmacological mechanism of Bailing capsule on chronic obstructive pulmonary disease: a meta-analysis and network pharmacology.

Ma G, Jin Y Pharm Biol. 2024; 62(1):803-817.

PMID: 39460586 PMC: 11514402. DOI: 10.1080/13880209.2024.2415643.


Long COVID Cardiopulmonary Symptoms and Health Resort Treatment: A Retrospective Study.

Onik G, Knapik K, Sieron K J Clin Med. 2024; 13(18).

PMID: 39337048 PMC: 11432736. DOI: 10.3390/jcm13185563.


Advances in nephroprotection: the therapeutic role of selenium, silver, and gold nanoparticles in renal health.

Karunakar K, Edwin E, Gopalakrishnan M, Cheriyan B, Ramaiyan V, Karthikha V Int Urol Nephrol. 2024; 57(2):479-510.

PMID: 39312019 DOI: 10.1007/s11255-024-04212-4.

References
1.
Kon S, Canavan J, Jones S, M Nolan C, Clark A, Dickson M . Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir Med. 2014; 2(3):195-203. DOI: 10.1016/S2213-2600(14)70001-3. View

2.
Ammous O, Feki W, Lotfi T, Khamis A, Gosselink R, Rebai A . Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev. 2023; 1:CD013778. PMC: 9817429. DOI: 10.1002/14651858.CD013778.pub2. View

3.
Alma H, de Jong C, Jelusic D, Wittmann M, Schuler M, Kollen B . Assessing health status over time: impact of recall period and anchor question on the minimal clinically important difference of copd health status tools. Health Qual Life Outcomes. 2018; 16(1):130. PMC: 6019834. DOI: 10.1186/s12955-018-0950-7. View

4.
Lacasse Y, Rousseau L, Maltais F . Prevalence of depressive symptoms and depression in patients with severe oxygen-dependent chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 2001; 21(2):80-6. DOI: 10.1097/00008483-200103000-00004. View

5.
Jones P . St. George's Respiratory Questionnaire: MCID. COPD. 2006; 2(1):75-9. DOI: 10.1081/copd-200050513. View